Agilon Health’s $2 Billion Secondary Offering and Repurchase of Common Stock

Debevoise & Plimpton LLP has advised agilon health (NYSE: AGL) and Clayton, Dubilier & Rice in the transaction.The transaction consiste in the secondary offering of approximately…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now